EFFICACY AND SAFETY OF COMBINED LIPID-LOWERING THERAPY IN PATIENTS WITH MIXED DYSLIPIDEMIA: DATA FROM A SURVEY OF EXPERT LIPIDOLOGISTS
Highlights Mixed dyslipidemia is an aggressive atherogenic phenotype that increases cardiovascular risk. When controlling LDL cholesterol with statins, there remains a high “residual” risk due to hypertriglyceridemia. The use of non‑statin drugs (fenofibrate, omega-3 PUFA) in combinations is limite...